By reducing the expression of pro-apoptotic proteins like BAX and increasing anti-apoptotic proteins like BCL-2, HDZJF likely helps to prevent cell death in the oral mucosa, promoting tissue regeneration and reducing ulcer severity. The gene discussed is BCL2; the disease is ulcer disease.